Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 5/20 | 0.53 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.53 |
| ▸ | PDE4A | P27815 | 9/20 | 0.51 |
| ▸ | PDE4B | Q07343 | 9/20 | 0.51 |
| ▸ | PDE4C | Q08493 | 9/20 | 0.51 |
| ▸ | PDE4D | Q08499 | 9/20 | 0.51 |
| ▸ | ADORA2B | P29275 | 4/20 | 0.50 |
| ▸ | PDE3B | Q13370 | 4/20 | 0.48 |
| ▸ | PDE3A | Q14432 | 4/20 | 0.48 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.48 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7066909 | 0.89 | ADORA2A (0.48) | ADORA2AADORA1PDE4APDE4BPDE4C | |
| SCHEMBL7071282 | 0.83 | PDE4A (0.53) | ADORA2AADORA1PDE4APDE4BPDE4C | |
| SCHEMBL7258507 | 0.82 | HRH4 (0.55) | CSNK2A1 | |
| SCHEMBL7070303 | 0.81 | PDE4A (0.59) | ADORA2AADORA1PDE4APDE4BPDE4C | |
| SCHEMBL7254511 | 0.79 | LMNA (0.56) | CSNK2A1 | |
| SCHEMBL7071470 | 0.79 | USP1 (0.51) | — | |
| SCHEMBL7070110 | 0.73 | LRRK2 (0.56) | ADORA2AADORA1PDE4APDE4BPDE4C | |
| SCHEMBL7071277 | 0.73 | PDE4A (0.56) | ADORA2AADORA1PDE4APDE4BPDE4C | |
| SCHEMBL24261356 | 0.72 | ADORA2A (0.79) | ADORA2AADORA1ADORA2B | |
| SCHEMBL7254519 | 0.71 | NPC1 (0.52) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2003055890-A1 | THIENOPYRIMIDINE DERIVATIVE COMPOUNDS AS INHIBITORS OF PROLYLPEPTIDASE, INDUCERS OF APOPTOSIS AND CANCER TREATMENT AGENTS | BAYER PHARMACEUTICALS CORPORATION (US) | 2003-07-10 | — | — | WO | disclosed |